PharmCADD Company
PharmCADD develops a new drug development platform that uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design. PharmCADD's products include Pharmulator, a consolidated drug discovery platform comprised of five core modules such as protein/RNA 3D structure prediction, drug generation, virtual screening, quantum calculation, and toxicity prediction to generate candidates with higher potential; and PharmVAC, a vaccine development platform that provides optimal solutions to users and clients to design, analyze, and visualize more probable RNA sequences for any vaccine candidates.
.jpg)
Founded Date:
2019-03-05
Industry:
Medicine and Biology
Headquarters:
Busan,Pusan-jikhalsi,South Korea,Asia
Employee Number:
51-100
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
19791949
Last Funding Total Usd:
16000000
Last Funding Total Currency:
USD
Last Funding Total Value:
16000000
Founders:
Taehyung Kwon
Categories:
Artificial Intelligence (AI),Biotechnology,Pharmaceutical
City:
Busan
Region:
Pusan-jikhalsi
Country:
South Korea